mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.02 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.02 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |